Form 4: SES AI Corp Executive Gan Hong Executes Option, Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Chief Science Officer Gan Hong exercised stock options and sold shares of SES AI Corp Class A Common Stock under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On March 1, 2024, Gan Hong, Chief Science Officer of SES AI Corp, exercised stock options to acquire 25,000 shares of Class A Common Stock at a price of $0.15 per share.
- Simultaneously, Gan Hong sold 25,000 shares of Class A Common Stock at a weighted average price of $1.6901, with individual sales ranging from $1.64 to $1.75.
- These transactions were executed under a Rule 10b5-1 trading plan established on September 5, 2023.
- Following these transactions, Gan Hong directly owns 875,001 shares of Class A Common Stock, which includes 819,153 shares underlying RSUs that are subject to vesting.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Industry Context
This filing is a routine disclosure of insider transactions and provides transparency to the market regarding executive stock ownership and trading activities. The use of a 10b5-1 plan suggests a pre-arranged strategy to avoid accusations of trading on inside information.
Comparison to Industry Standards
- Executive stock option exercises and sales are common in publicly traded companies, particularly in the technology sector.
- The use of Rule 10b5-1 plans is a standard practice to allow insiders to trade company stock without concerns about insider trading violations.
- Comparable companies like QuantumScape or Solid Power also have executives who regularly report stock transactions via Form 4 filings.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the use of a 10b5-1 plan mitigates concerns about insider trading.
- The transactions do not appear to have a direct impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 2019-03-14 | Date of fully vested options grant. |
| 2023-09-05 | Date the Rule 10b5-1 plan was entered into by the Reporting Person. |
| 2024-03-01 | Date of option exercise and stock sale. |
| 2024-03-04 | Date of Form 4 filing. |
| 2029-03-13 | Expiration date of stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.